Phillip D. Toth

Internal Medicine

8803 N Meridian St Ste 200
Indianapolis, IN 46260

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study.

Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study.

Journal: Obesity (Silver Spring, Md.)

Published: July 25, 2025

Showing 1-1 of 1

Last Updated: 09/26/2026